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Background:  The FIP 2018 global pharmacy workforce report identified that the pharmacy 
workforce is facing increasing capacity challenges and predicted that globally, the pharmacy 
workforce would grow by 40% over the next 15 years. The purpose of this report was to 
specifically examine the pharmacist workforce in Ireland over the last 15 years with reference 
to a number of developments that have both directly and indirectly affected the capacity of the 
pharmacy sector. A second objective was to benchmark the pharmacy workforce capacity in 
Ireland against other countries of similar demographic and economic standing in order to assess 
how Ireland compares.  
Methods: Data was collected from PSI Annual Reports, Eurostat, OECD, PHARMINE 
Reports, UCAS, CSO Census Reports, WHO and FIP Global Pharmacy Workforce Reports 
regarding the pharmacy workforce in Ireland and selected comparison countries. Comparison 
countries were chosen based on population, GDP/capita, healthcare expenditure and HDI 
values. The data was analysed and presented using graphs and tables.  
Results: The number of pharmacists in Ireland has increased by 90% over the last 15 years. 
Despite two new Schools of Pharmacy opening in 2002 (RCSI) & 2003 (UCC), 57% of new 
registrants to the PSI over the last 15 years qualified via the EU route, predominately from the 
UK. Since the first graduates from RCSI and UCC qualified, PSI registrants via the national 
route range between 27-56% of total additions annually. Ireland’s output of pharmacy 
graduates per population is 40% lower than the UK and the number of pharmacy graduates per 
school of pharmacy in the UK is over twice that of Ireland.  Ireland has the second highest 
number of pharmacies per 100,000 population out of 10 comparator countries.  Ireland also has 
the joint highest number of pharmacists per 100,000, based on the total number of pharmacists 
registered with the PSI.  This includes 5.5 % of PSI registrants who are in non-patient facing 
roles, 2.5% who are not-practicing/other and 21.5% of registrants who do not state their area 
of practice, with only 70.5% of registrants declaring as ‘patient-facing’.   
Conclusions: The pharmacy workforce in Ireland is highly dependent on new registrants 
applying via the EU mutual recognition route, predominantly from the UK. Any interruption 
to mutual recognition of pharmacists between the EU and UK, as a result of Brexit, would 
significantly affect the capacity of pharmacy services in Ireland.  Compared to similar EU 
countries, pharmacists/pharmacies per head of population is relatively high. However, 
estimates of pharmacy workforce in Ireland based on all pharmacists registered with the PSI 
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may overestimate capacity in Ireland.  In order to meet global trends of the increasing number 
of patients needing access to pharmacy related services and diversification of pharmacist roles, 
ongoing review of capacity in pharmacy is essential.  
  
Key Highlights 
• The number of pharmacists in Ireland has increased by 90% over the last 15 years.   
• There has been a 47% increase in the number of pharmacies in Ireland during the same time. 
• Despite the opening of RCSI and UCC Schools of Pharmacy in 2002 and 2003 respectively, 57% of 
new PSI registrants over the last 15 years qualified via the EU route, predominately from the UK. 
• Ireland’s output of pharmacy graduates per population is 40% lower than the UK and the 
number of pharmacy graduates per school of pharmacy in the UK is over twice that of Ireland. 
• Any risk to the free movement and mutual recognition of pharmacists between the UK and EU 
as a result of Brexit would lead to significant shortages of pharmacists in Ireland. 
• Of 10 comparator EU countries, Ireland has the joint highest number of pharmacists and the 
second highest number of pharmacies per head of population.  
• Pharmacy workforce estimates in Ireland are based on total registrants on PSI, which may 




Numerous WHO reports have identified an increasing demand from patients for healthcare 
services and the availability of a well-educated, competent healthcare professionals is crucial 
to meeting the pharmaceutical care needs of patients. Pharmacists are a key component of the 
healthcare workforce, and are usually the most accessible healthcare profession.  In Ireland, 
over two million people visit a community pharmacy each month and twenty million 
prescriptions are filled annually (1). The pharmacist is uniquely positioned at the key interface 
between medicines and the patient in a primary care setting. Meeting the pharmaceutical care 
needs of patients can only be maintained with an adaptable pharmacy workforce, equipped with 
the necessary knowledge, skills, expertise and resources.  The WHO estimates that there is a 
global healthcare workforce shortage of 7.2 million due to numerous factors including 
increasing national populations, longer life expectancies, increasing healthcare costs, and 
rapidly growing demands for health services and burden of chronic diseases (2). Specifically, 
in pharmacy services, the 2018 FIP report identified that pharmacy workforce is facing 
increasing capacity challenges and predicted a 40% growth of the global pharmacy workforce 
over the next 15 years (3).   
It is over two decades since Peter Bacon and Associates were commissioned by the Higher 
Education Authority to prepare a report on pharmacy workforce in Ireland ‘against a backdrop 
of evidence, both formal and anecdotal, that the Irish pharmacy profession had been 
experiencing excess demand for labour’(4). The ‘Bacon report’ confirmed that there was a 
shortage of pharmacists across community, hospital and industry settings and the existing 
output of pharmacists in Ireland from Trinity College Dublin was not sufficient. The 
recommendations of the report were that the HEA should invite proposals from other 3rd level 
institutions for new schools and complete a costs-benefit evaluation of the proposals.  
Following on from this report, two new pharmacy schools were opened, The Royal College of 
Surgeons (RCSI) School of Pharmacy in 2002 and University College Cork (UCC) School of 
Pharmacy in 2003.  
Since then, there has been no independent systematic study on the pharmacy workforce in 
Ireland to assess the impact of these two new schools of pharmacy on the pharmacist workforce 
in Ireland. This study examines pharmacist and pharmacy numbers in Ireland over the last 15 
years in conjunction with economic and demographic data to allow improved understanding 
and trending of pharmacy workforce descriptors in Ireland. By examining the evolution of the 
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workforce, conclusions can be drawn regarding factors that have impacted the supply of 
pharmacists and forecasts can be made regarding factors that may impact pharmacist numbers 
into the future. 
The FIP global pharmacy workforce analyses identified that pharmacy workforce capacity 
varies considerably between developed and low income/developing countries and regions and 
generally correlates with population- and country-level economic indicators(3).  Therefore, 
there is a need at a national level to compare pharmacy workforce in Ireland to comparable 
countries.  This study aims to benchmark Ireland against countries with similar demographic 
and economic descriptors in order to draw accurate and representative conclusions.  By 
comparing the pharmacist workforce in Ireland to other countries under headings including 
workforce capacity descriptors, pharmacy education, and population dynamics, it is possible 
to see where Ireland lies on a scale relative to other countries. Analysis of resulting variations 
and/or correlations between Ireland and countries of similar economic, demographic and social 
standing, will support informed decision making regarding the capacity of pharmacist 
workforce, identify potential capacity gaps and predict pharmacy workforce training needs into 






A literature review was conducted using the Web of Science database. Keywords and terms 
such as ‘pharmacy workforce’, ‘pharmacy workforce Ireland’, ‘manpower in pharmacy’, 
‘pharmacist shortage’, ‘pharmacy in EU’, ‘UK pharmacist workforce’, ‘Brexit’ etc. were used.  
Data was gathered from sources including: The Pharmaceutical Society of Ireland (PSI) Annual 
Reports 2004-2016, Eurostat (the statistical office of the EU), The Organisation for Economic 
Co-operation and Development (OECD), The PHARMINE Report 2011, The Central Statistics 
Office (CSO) Census Reports 2002, 2006, 2011, 2016. The World Health Organisation 
(WHO), International Pharmaceutical Federation (FIP) Workforce Reports, The Universities 
and Colleges Admissions Service (UCAS). All of these sources were available online.   Further 
information and clarification and breakdown of PSI Annual Reports was obtained from a 
contact in the PSI Communications Unit.   All collected data was input into Microsoft Excel 
for further analysis. Analysed data was presented using graphs and tables.  
It was decided that comparison countries should be part of the EU/EEA and the OECD. The 
countries chosen were selected based on the following criteria: total population, GDP/capita 
($), % of GDP spent on healthcare, % of total government spending on healthcare and Human 
Development Index (HDI) values. For each of these variables a list was made of countries with 
values similar to that of Ireland. The lists were cross referenced and any country that appeared 










Table 1. Table showing selection criteria for comparison countries. Countries shaded occur in three or more of 




World Bank (5) 
GDP/capita ($) 
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% GDP spent 
on healthcare 
 











Ireland (4.773) Ireland (61,606) Ireland (7.8) Ireland (19.3) Ireland (0.923) 
















Finland (5.495) Netherlands 
(45,295) 










Italy (8.9) Germany (16.3) Norway (0.949) 
Austria (8.747) Sweden 
(51,600) 
Portugal (8.9) Denmark (15.6) Sweden (0.913) 
Sweden (9.903) Finland 
(43,090) 
Slovenia (8.6) Austria (15.5) Iceland (0.921)* 
 Iceland 
(59,977)* 





France (14.3) France (0.897) 
 Germany 
(41,936) 
Poland (6.4)  Luxembourg 
(0.898) 
  Slovakia (6.9)  Belgium (0.896) 
    Austria (0.893) 
    Finland (0.895) 
*Iceland omitted – population too small to draw accurate conclusions 






Pharmacy workforce over the past 15 years – an Irish Perspective 
 
 
Figure 1. Graph showing total number of pharmacists added to the PSI register annually via national and EU 
routes and total number of pharmacists in Ireland (cumulative) between 2003 and 2017. Data taken from PSI 
Annual Reports 2004-2016 and PSI Statistics(9). 
The total number of pharmacists in Ireland increased from 3,208 in 2002 to 6,097 in 2017 – an 
increase of 90%. On an annual basis, the average number of new additions to the PSI register 
is 341, qualifying by either the national, EU or 3rd country routes. Pharmacists that have trained 
at one of the three schools of pharmacy in Ireland register via the national route. The number 
of pharmacists added via the national route annually has increased from an average of 71 from 
2003-2006 to an average of 153 from 2007-2017. This is primarily a reflection of the increase 
in pharmacy graduates nationally coming from RCSI and UCC Schools of Pharmacy, which 
opened in 2002 and 2003 respectively. An initial spike in registration via the national route was 
seen in 2007 when the first year of RCSI graduates registered with the PSI. This further 
increased in 2008 when the first UCC graduates were added. Since then numbers have 
remained constant, ranging between 140-170 each year. Fluctuations within these limits 
represent differences in the uptake of the BPharm degree by CAO applicants and varying drop-










































National Route EU Route Total number of pharmacists (cumulative)
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Under Directive 2005/36/EC there is mutual recognition of professional qualifications which 
enables the free movement of pharmacists between EU member states.  The number of 
pharmacists that registered with the PSI via the EU/EEA route has seen substantial fluctuation 
over this 15 year period. Numbers increased dramatically from 2004, peaking in 2007 (306 
registrants), most likely coinciding with the high demand for pharmacists, driven in no small 
part by the ‘Celtic Tiger’ economy of the time. The addition of ten new EU countries in 2004 
meant that under Directive 2004/38/EC citizens of these countries could now move and reside 
freely within any member state without obtaining a work permit. Immigration flows in Ireland 
exceeded 100,000 per year between 2006-2007 (10). These higher levels of immigration into 
Ireland brought increased demand for pharmacy related services and increased demand for 
pharmacists, resulting in a peak in the number of EU/EEA registrants at the same time.  The 
numbers of EU registrants sharply declined from 2007-2009 as Ireland was hit by recession, 
reduced healthcare budget cuts and net migration out of Ireland. The number of EU pharmacists 
registering with the PSI fell by 66% between 2007-2009. Despite the downturn in EU 
registrants during 2007-2009, total pharmacist numbers in Ireland remained relatively static as 
the decrease in registrants via the EU route was counteracted by the increase in registrants via 
the national route at the same time. Registrant numbers via the EU route have recovered since 
2009 and stabilized at between 43% to 58% each year since. The flexibility and adaptability of 
the EU professional workforce to match local demand is clearly a positive outcome of the EU 
mutual recognition agreement, allowing for flexible workflows across the EU and movement 
of the workforce to match the natural fluctuations in economic cycles of the various countries 
across Europe. 
In terms of registration from other ‘3rd countries’, the overall number of registrations via this 
route are relatively few, with an average of only 4 pharmacists per year registering via this 
route since 2010.  The third county route of registration commenced in 2010 through which 
pharmacists outside the EU/EEA register with the PSI. Prior to 2006, reciprocal registration 
agreement operated on the basis that pharmacist qualifications were mutually recognized 
between Ireland-New Zealand and Ireland-Australia. Between 2003-2006 an average of 49 
pharmacists per year registered via this reciprocal registration approach.  However, this route 





Brexit  - A potential risk to the Irish Pharmacy workforce 
 
Despite the increase in pharmacists qualifying nationally in recent years, it is clear from the 
above data that the pharmacist workforce in Ireland is heavily reliant on pharmacists that are 
qualifying outside of Ireland, with the vast majority training in the UK. Since 2003, 62% of 
new registrants to the PSI have qualified outside of Irish universities, with 57% via the EU 
route and 5% via 3rd country and reciprocal routes.  The vast majority of EU qualified new 
registrants are trained in the UK/Northern Ireland (i.e. in 2017 113 out of 170 EU qualified 
registrants were trained in UK/NI) and it would seem reasonable to assume the majority are 
Irish students who studied pharmacy at a UK university.   
Leaving aside the socioeconomic debate surrounding the national policy on limiting pharmacy 
places in Irish universities to less than 50% of the current labour market needs, it is clear that 
pharmacy services remain highly reliant on Irish students training at schools of pharmacy in 
the UK.  It is unclear as of yet the extent to which the free movement and mutual recognition 
of pharmacy qualifications will be upheld/withdrawn when the UK leaves the EU. However, 
any restrictions to this free movement will have a substantial impact on the pharmacist 
workforce. For this reason, Brexit poses a significant risk to the future capacity of the 
pharmacist workforce in Ireland.  
The uncertainty around Brexit is also likely to impact on the numbers of Irish students applying 
to study in the UK through UCAS(11). Since June 2016, the overall number of applicants has 
fallen from 5,680 in 2015 to 4,100 in 2018. This represents 28% decrease in students, and while 
this study did not examine precise figures on the number of Irish students registering at schools 
of pharmacy in the UK, it is reasonable to assume that there will be a significant reduction in 
the number of Irish students qualifying as pharmacists in the UK from 2020/21 onwards. While 
the implications of Brexit are as of yet uncertain, the risk of Brexit to pharmacy capacity is 




Access to pharmacy services over the past 15 years – an Irish Perspective 
 
 
Figure 2. Total number of registered pharmacists and pharmacies in Ireland between 2003-2017 (9). 
 
 
Figure 3. Graph showing the number of pharmacists per 100,000 population, number of pharmacies per 
100,000 population, average number of pharmacists per pharmacy and population per pharmacy in Ireland 
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As a result of the increase in the number of pharmacists in Ireland over recent years, the number 
of pharmacists per 100,000 population has increased from 80 to 127 between 2003-2017. The 
number of pharmacists per pharmacy increased from 2.4 to 3.16 over the same period. The 
total number of pharmacies in Ireland has consistently increased in Ireland over the last 15 
years.  In 2003 there were 1’317 pharmacies, by the end of 2017 this number increased to 
1’932. As a result of this the number of pharmacies per 100,000 population has increased from 
33 to 40.2. As the number of pharmacies has increased, the population per pharmacy has 
reduced. In 2003 the population per pharmacy was 3’034, which has decreased to 2’487 by the 
end of 2017. This has resulted in increased patient access to pharmacists in a community 
setting, facilitating greater provision of primary healthcare services, and has also increased 
competition in the sector.  
Pharmacy capacity in Ireland compared to other EU countries 
 
With the aim of benchmarking the pharmacist workforce in Ireland to other countries a number 
of comparison countries were chosen based on a range of demographic and economic 
descriptors, as described the methods section. This ensured that the chosen countries broadly 
share common goals in terms of economic, environmental, social and healthcare standards, 
therefore, justifying that comparisons between these countries are appropriate.  
 
Population density of Pharmacists and Pharmacies in comparison countries 
 


























Austria 71 15.4 4.61 6,494 
Belgium 121 43.9 2.76 2,278 
Denmark 51 3.9 13.08 25,641 
Finland 110 14.9 7.38 6,711 
Germany 64 24.8 2.58 4,032 
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Ireland 121 40.2 3.0 2,488 
Netherlands 21 11.7 1.80 8,547 
Norway  74 15.0 4.93 6,667 
Sweden 76 13.3 5.71 7,519 
Switzerland 54 21.3 2.54 4,695 
UK 83 22.1 3.76 4,525 
Median 74 15.4 3.76 6,494 
 
 
Figure 4. Number of pharmacists and pharmacies per 100,000 population (2015) in comparison countries. 
Patient facing pharmacists in Ireland (i.e. community and hospital based) also shown.  
Ireland and Belgium have the joint highest number of pharmacists per 100,000 population 
(121) while the Netherlands has the lowest (21). However, it should be noted that the data for 
Ireland represents all pharmacists licenced to practice – i.e. all pharmacists on the PSI register. 
As a result, pharmacists that are not practicing in patient facing roles, such as industry, 
academia, regulation etc. are included, which may over-estimate pharmacy workforce capacity. 
As of the 1st of October 2018, 70.5% of registered pharmacists identified as working in patient 
facing roles (i.e. community or hospital pharmacy), 5.5% identified as working in non-patient 
facing roles (i.e. academic, industry, regulatory), 2.5% identified as non-practicing or ‘other’.  
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However, 21.5 % of pharmacists did not state their area of practice(12). This is a substantial 
proportion and leaves much room for error when estimating the total percentage of patient 
facing and non-patient facing pharmacists in Ireland and pharmacy capacity predictions.  
Therefore, using the total number of pharmacists when comparing to other countries leads to a 
misleading assessment of the capacity of the patient-facing sectors of pharmacy practice.  
Based on the total number of registrants on the PSI register, Ireland is significantly above the 
median in terms of the number of pharmacists per population. Using the adjusted figure of 70% 
reporting as ‘patient facing’ brings the overall figure in line with the comparison countries. It 
was unclear if the figures given for the comparison countries reflect all pharmacists registered 
with the national professional body or registered to practice on in ‘patient facing’ roles, and is 
therefore a limitation of the current study.  While ‘non-patient’ facing pharmacists roles are 
varied and may contribute indirectly to improving accessibility to medicines, clearly 
segmentation of the data to allow comparisons of ‘patient facing’ pharmacist density between 
countries will allow more reliable benchmarking in the context of access of patients to 
pharmacy related services.  
Ireland has the second highest number of community pharmacies per 100,000 population (40.2) 
after Belgium (43.9). Denmark has the lowest (3.9). However, it is important to be cognisant 
of the national requirements level of regulation of the pharmacy sector in each country before 
drawing conclusions. Table 3 compares the regulation of ownership, location of pharmacies 
and sale of OTC medicines across the comparator countries.  
 
Table 3. Restrictions on ownership and location of pharmacies and sale of OTC medicines. Taken from 















Austria     
Belgium X X   
Denmark    X 
Finland     
Germany   X  
Ireland  X X X X 
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Netherlands X X X X 
Norway X   X 
Sweden X X X X 
Switzerland X X X X 
UK X X X X 
 
In Denmark, the establishment of pharmacies is highly regulated and it has the lowest number 
of pharmacies per 100,000 population at 3.9. In Denmark, only pharmacists can own 
pharmacies, multiple ownership is not permitted and there are no pharmacy chains (15). The 
average population per pharmacy in Denmark is ~25,641 – this is over 10 times the Irish 
average. The average number of pharmacists per pharmacy in Denmark is by far the highest of 
the comparison countries at 13.08 in order to cater for the large volume of patients in each 
pharmacy.  
The pharmacy sector in Ireland is deregulated, there are limited restrictions on the ownership 
and location of pharmacies (13, 15). The average population per pharmacy in Ireland is the 
second lowest at 2,488 after Belgium. The average population per pharmacy in the other 
countries (excluding Denmark) ranges from 4,000 to 8,000 which indicates that Ireland’s 
numbers are below the European average. The aim of deregulating the establishment of 
pharmacies is to improve accessibility to medicines and improve competition on the price of 
medicines. However, it can often lead to an irregular spread of pharmacies, favouring 
development in urban areas over rural areas (15). Even though the establishment of pharmacies 
in Ireland is deregulated, when compared with other countries with a similar level of 
deregulation (UK, Sweden, Netherlands) Ireland still has a much higher number of pharmacies 
per 100,000 population. This demonstrates that this is not simply a product of deregulation and 




Figure 5. Number of pharmacies per 100,000 population in 2007 and 2015 in comparison countries(6). 
At a glance, it is clear that Belgium has the highest number of pharmacies per 100,000 
population, followed by Ireland. However, it is important to note that pharmacy numbers have 
decreased in Belgium between 2007-2015 while numbers are continuing to increase in Ireland. 
This illustrates that even though Belgium has the highest number of pharmacies currently, if 
current trends continue Ireland will overtake it. Even though other countries (Norway, Sweden, 
UK) have shown increases in pharmacy numbers in recent years, their numbers are still far 
below Ireland.  The total number of pharmacies per 100,000 population in Ireland is still twice 
that of the UK.  
Pharmacist training in comparison countries   
 

























Austria 252 2.95 3 84 
Belgium 626 5.58 9 70 
Denmark 81 1.44 2 40.5 






















Pharmacies/100,000 (2007) Pharmacies/100,000 (2015)
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Germany 2079 2.57 22 94.5 
Ireland 151 3.27 3 50.3 
Netherlands 239 1.42 2 119.5 
Norway  185 3.6 5 46.25 
Sweden 375 3.87 2 187.5 
Switzerland 208 2.54 6 34.7 
UK  3545 5.49 25 141.8 




Figure 6. Number of pharmacy graduates per 100,000 population and average number of graduates per school 
of pharmacy (2014) in comparison countries (6, 13). 
Ireland lies exactly on the median set by the comparison countries in terms of pharmacy 
graduates per population. However, the number of graduates per school of pharmacy in Ireland 
is below the median at an average of 50 graduates per school. In the UK, the average number 
of graduates per school of pharmacy annually is ~114 – more than double the Irish figure.  
These two indicators of pharmacy education in Ireland show that despite the addition of RCSI 
and UCC Schools of Pharmacy, Ireland’s output of national pharmacy graduates is still low 
relative to other comparison countries.  This again reinforces the point that Ireland is heavily 
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reliant on the movement of pharmacists into Ireland from other countries in order to meet 
demand and anything that would interrupt this flow of non-nationally trained pharmacists 
would have a significant impact on the pharmacy workforce in Ireland.  
Over 65’s population dynamics in comparison countries  
 













Austria 18.5 38.376 
Belgium 18.2 66.486 
Denmark 18.8 27.129 
Finland 20.5 53.663 
Germany 21.1 30.19 
Ireland 13.2 84.09 
Netherlands 18.2 11.538 
Norway  16.4 51.829 
Sweden 19.8 38.39 
Switzerland 18 30 
UK 17.9 46.928 





Figure 7. Graph showing the percentage of the population over 65 and the number of pharmacists per 10,000 
65 and over population(16, 17). 
 
The percentage of the population over the age of 65 is the lowest in Ireland out of the 
comparison countries. Despite the fact that Irelands population is the youngest of the 
comparator countries, between 2011-2016 this age group increased by 19.1%. This makes it 
the fastest growing age-group in the country. Use of prescription medicines is highest in this 
population, there is an exponential increase in the prevalence of disease and polypharmacy as 
age increases. 62% of people in Ireland over the age of 65 have one or more chronic illnesses. 
By 2020, 40% of the population of Ireland is expected to have a chronic illness. The supply of 
pharmacists must be capable of providing medicines access to meet this increasing need.  
 
Another potential consideration affecting overall capacity in workforce is increasing 
feminization of the pharmacy workforce (2).  Global trends indicate the proportion of females 
in the pharmacy workforce is increasing and it is predicted to exceed 72% by 2030(3).  In 
Europe, % female pharmacists between 2009 and 2016 increased from ~66 to ~68%.  The % 
females on the PSI register as of 1st November 2018 was 65%, so Ireland is marginally below 
European average and therefore also likely to increase. The average annual full-time equivalent 
contribution of females is lower than that of males, due to a larger proportion of female 
pharmacists who work part-time and who prefer more flexible work patterns (18, 19).  While 
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career for women, gender profile is also relevant to overall workforce capacity considerations 
as this could lead to a lower overall capacity for the pharmacy workforce.   
 
Key findings 
• The number of registered pharmacists in Ireland has increased by 90% over the last 15 
years. The number of pharmacies has increased by 46% during this time. This shows significant 
growth and continued demand for pharmacy services in Ireland.   
• Despite two new Schools of Pharmacy opening during the 15 period, 57% of additions 
to the register during this time were via the EU route, predominantly from the UK.  The 
pharmacist workforce continues to be heavily dependent on pharmacists that are trained outside 
of Ireland. In 2017 alone for example, ~66% of additions to the register via the EU route came 
from the UK. This highlights a key risk that Brexit poses. Any restriction to the free movement 
of pharmacists between the UK and Ireland is likely to lead to workforce shortages in Ireland 
and negatively impact patient accessibility to pharmacy related services. 
• Estimates based on total number of PSI registrants is likely to overestimate pharmacy 
workforce capacity in Ireland.  In order to relate pharmacist density to accessibility of 
medicines, there is a need for a more comprehensive breakdown of the PSI register into patient-
facing and non-patient facing pharmacists. Currently, 70.5% of PSI registrants are ‘patient 
facing’ however, 21.5% of pharmacists do not state their area of practice. This results in 
inaccuracies when comparing pharmacy workforce capacity with other countries.  
• Ireland has the second highest number of community pharmacies per 100,000 
population after Belgium. However, pharmacy numbers in Belgium have decreased in recent 
years while numbers in Ireland have continued to increase. The total number of pharmacies per 
100,000 population in Ireland is currently twice that of the UK.  
• Ireland’s output of pharmacy graduates nationally is below average when compared to 
the other countries despite the addition of RCSI and UCC Schools of Pharmacy. In the UK for 




Conclusion and future perspectives 
It is almost two decades since the last systematic study was performed on the pharmacist 
workforce in Ireland. The economic boom, the recession, significant cuts to the pharmacy 
sector, EU enlargement and the opening of two new schools of pharmacy have all had a part to 
play in the evolution of the pharmacist workforce during this time. The impact of Brexit, the 
increasing clinical role of the pharmacist and the increasing and ageing population of Ireland 
will continue to create demands on the pharmacist workforce in Ireland into the future.  
With the increasing shift towards patient centred pharmacy related services, clinical decision-
making on medicine use, and expanding roles of pharmacists, it is imperative to continually 
evaluate the capacity of the pharmacist workforce, in order to balance the demand versus 
supply of pharmacists.  Pharmacists now play a much more active role in optimising patient 
treatment, promoting the safe and rational use of medicines, diagnosis and ongoing monitoring 
of disease and the promotion of general health and wellbeing through public health initiatives 
such as vaccination programmes. However, in a baseline study of community pharmacy 
practice in Ireland conducted in 2011, 81.2% of responders identified dispensing prescriptions 
as the taking up most of their time on most days (20). Other key activities included counselling 
on the use of medications and giving advice about minor illness. This limits time available to 
offer expanded pharmacy services to patients. Analysing the status of the pharmacy workforce 
is important if workforce challenges are to be addressed and workforce risks mitigated. Global 
trends indicate that over the next 15 years, the pharmacy workforce needs to increase by up to 
40% to meet demand for expanded pharmacy related services.  While Ireland already has a 
high pharmacist per capita ratio relative to comparator countries, it is still likely that demand 
for pharmacists will continue to increase here, and workforce challenges due to Brexit and 
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